SCHEMBL6709019

SCHEMBL6709019

COCC(=O)Nc1cccc2cc(C(=O)Nc3ccc(C#N)cc3-c3noc(=O)[nH]3)[nH]c12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.37
TP53 P04637 3/20 0.36
POLB P06746 3/20 0.35
LMNA P02545 3/20 0.35
MAPT P10636 2/20 0.35
PLA2G7 Q13093 1/20 0.34
ADORA3 P0DMS8 2/20 0.34
ADORA2A P29274 2/20 0.34
ADORA2B P29275 2/20 0.34
NSD2 O96028 1/20 0.34
HDAC3 O15379 2/20 0.34
HDAC1 Q13547 2/20 0.34
PARP14 Q460N5 1/20 0.33
MAPK1 P28482 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
KDM4E B2RXH2 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
THRB P10828 1/20 0.32
ADORA1 P30542 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6708856 0.93 ALB (0.35) GAATP53POLBLMNAMAPT
SCHEMBL6709934 0.92 TP53 (0.36) TP53POLBLMNAMAPTPLA2G7
SCHEMBL6709008 0.91 MAPT (0.36) TP53POLBLMNAMAPTPLA2G7
SCHEMBL6710078 0.91 ALDH1A1 (0.37) GAATP53POLBLMNAMAPT
SCHEMBL6709031 0.90 PLA2G7 (0.37) TP53POLBLMNAMAPTPLA2G7
SCHEMBL6710395 0.90 PKM (0.35) TP53POLBLMNAMAPTPLA2G7
SCHEMBL6713217 0.89 HDAC3 (0.38) TP53POLBLMNAMAPTPLA2G7
SCHEMBL6710445 0.89 POLB (0.39) TP53POLBLMNAMAPTPLA2G7
SCHEMBL6711833 0.89 PLA2G7 (0.36) TP53POLBLMNAMAPTPLA2G7
SCHEMBL6710215 0.89 MAPT (0.36) TP53POLBLMNAMAPTPLA2G7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed
WO-2004018461-A2 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 GAA 111/4885TP53 2699/4885POLB 626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.